Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Veracyte, Inc.

< Previous 1 2 3 4 5 Next >
Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data Demonstrate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Publication Demonstrates Ability of Veracyte’s Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive Year
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Second Quarter 2021 Financial Results
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Release Second Quarter 2021 Financial Results on July 29, 2021
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
CORRECTING and REPLACING Veracyte to Present at Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Present at Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Present at Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.